Enantiomeric Compounds With Antibacterial Activity
申请人:GUILES Joseph
公开号:US20080108651A1
公开(公告)日:2008-05-08
Novel compounds in enantiomeric excess that are inhibitors of bacterial methionyl synthetase (MetRS) are disclosed. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, and in particular their use in therapy for
Clostridium difficile
infection.
Enantiomeric compounds with antibacterial activity
申请人:Crestone, Inc.
公开号:US07973050B2
公开(公告)日:2011-07-05
Novel compounds in enantiomeric excess that are inhibitors of bacterial methionyl synthetase (MetRS) are disclosed. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, and in particular their use in therapy for Clostridium difficile infection.
ENANTIOMERIC COMPOUNDS WITH ANTIBACTERIAL ACTIVITY
申请人:Crestone, Inc.
公开号:EP2091536A2
公开(公告)日:2009-08-26
US7973050B2
申请人:——
公开号:US7973050B2
公开(公告)日:2011-07-05
[EN] ENANTIOMERIC COMPOUNDS WITH ANTIBACTERIAL ACTIVITY<br/>[FR] COMPOSÉS ÉNANTIOMÈRES À ACTIVITÉ ANTIBACTÉRIENNE
申请人:REPLIDYNE INC
公开号:WO2008039640A2
公开(公告)日:2008-04-03
[EN] Novel compounds in enantiomeric excess that are inhibitors of bacterial methionyl synthetase (MetRS) are disclosed. Also disclosed are methods for their preparation and their use in therapy as antibacterial agents, and in particular their use in therapy for Clostridium difficile infection. [FR] L'invention concerne de nouveaux composés en excès énantiomère étant des inhibiteurs de la méthionyl synthétase bactérienne (MetRS). L'invention concerne également des procédés de préparation de ces composés et leur utilisation en thérapie en tant qu'agents antibactériens, notamment dans la thérapie d'infections par clostridium difficile.